Clinical Trial Update: Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effects of nine months of SPIRIVA on health-related quality of life in patients with chronic obstructive pulmonary disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED